Oral Presentation: Angiostatin inhibits neutrophil migration and activation

G. Aulakh (Saskatchewan, Canada)

Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Number: 6
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Aulakh (Saskatchewan, Canada). Oral Presentation: Angiostatin inhibits neutrophil migration and activation. Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral Presentation: Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011



Oral Presentation: The functional role of the Frizzled-8 receptor TGF-beta1-induced activation and extracellular matrix production in human lung fibroblasts
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Inhibition of human lung H460 cell proliferation by siRNA-mediated macrophage migration inhibitory factor (MIF) blocking
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013

Oral presentation: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Removal of extracellular ATP improves fMLP-induced neutrophil chemotaxis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Remifentanil attenuates LPS-induced neutrophil activation
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012

Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015


GB001 potently inhibits PGD2 metabolite-induced DP2-mediated cell signaling and eosinophil activation
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Migration of human monocytes is stimulated by Jagged-1 and DLL-4 via the notch pathway
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014

Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014

Effect of doxofylline on LPS-induced leukocyte migration to the lung
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Roflumilast inhibits leukocyte cell interactions in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006

Neutrophil activation by FMLP and IL-8: differences in involvement of RhoA
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001

Interactions between neutrophils and NSCLC cells in vitro – effects on neutrophil inflammatory mediator generation and tumor cell proliferation
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Role of 15-lipoxygenase in the polarization of human lung macrophages
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013